Standout Papers

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma 2007 2026 2013 2019 2.8k
  1. Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma (2007)
    Gary R. Hudes, Michael A. Carducci et al. New England Journal of Medicine

Immediate Impact

5 by Nobel laureates 31 from Science/Nature 80 standout
Sub-graph 1 of 20

Citing Papers

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline
2022 Standout
DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer
2021 StandoutNature
20 intermediate papers

Works of Zoran Kovačević being referenced

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
2007 Standout

Author Peers

Author Last Decade Papers Cites
Zoran Kovačević 91 242 35 2039 1991 29 2.9k
Erhan Gökmen 63 257 17 2198 2049 54 3.3k
Janice Dutcher 79 269 20 2516 2351 13 3.6k
Debasish Roychowdhury 78 278 14 2053 1453 19 3.0k
Herbert T. Cohen 114 265 29 1277 2443 38 3.3k
Stephanie Lustgarten 60 238 109 2055 2039 60 3.5k
Chen Mei 55 274 18 2107 1556 59 2.9k
Norbert Hollaender 93 291 67 2459 2365 29 3.9k
Vladimir Lesovoy 64 259 15 2294 2178 8 3.4k
James R. Vasselli 22 387 24 1156 1599 36 3.6k
Lauren McCann 70 171 17 2463 1917 30 3.0k

All Works

Loading papers...

Rankless by CCL
2026